Evidence map›Paper›PMID 12685991›Full record

ReviewCurrent psychiatry reports2003

Linkage and association studies of schizophrenia.

Peter McGuffin, Kopal Tandon, Alejandro Corsico

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current psychiatry reports, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Relationship betweenIranian journal of public health · 2021
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Molecular genetics of schizophrenia: a critical review.Journal of psychiatry & neuroscience : JPN · 2003
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Peter McGuffinSGDP Research Centre, Institute of Psychiatry, King's College London, De Crepigny Park,London SE5 8AF, UK. p.mcguffin@btinternet.com
Kopal Tandon
Alejandro Corsico

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent twin studies confirm that schizophrenia is highly heritable, but attempts to locate and identify genes have proved to be difficult. This is largely because major genes appear to be rare or nonexistent. Instead, genetic liability almost certainly results from the combined effects of multiple susceptibility loci and most studies have been under-equipped to detect such effects. Nevertheless, several regions of the genome have been implicated by more than one linkage study and chromosome 22q has been implicated by linkage and by studies of patients with microdeletions. Recent work attempting to refine regions of interest using linkage dysequilibrium mapping has identified four promising and novel "positional candidates;" they are neuregulin-1 on chromosome 8p-p21, G72 located at chromosome 13q34, dysbindin at 6p22.3, and proline dehydrogenase, which is a gene that maps to chromosome 22q11. In addition, there is renewed interest in a fifth gene, catechol-O-methyltransferase, also on chromosome 22q11.

Indexed as

Carrier ProteinsCatechol O-MethyltransferaseChromosome MappingChromosomes, Human, Pair 13Chromosomes, Human, Pair 22Chromosomes, Human, Pair 8DysbindinDystrophin-Associated ProteinsGenetic LinkageHumansNeuregulin-1Proline OxidaseReceptors, N-Methyl-D-AspartateSchizophreniaCarrier ProteinsCatechol O-MethyltransferaseDTNBP1 protein, humanDysbindinDystrophin-Associated ProteinsNeuregulin-1Proline OxidaseReceptors, N-Methyl-D-Aspartate

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.